The CHD (chromodomain helicase DNA-binding) family of proteins are ATP-dependent chromatin remodelers that play a crucial role in the regulation of gene expression. These proteins possess a chromodomain, enabling them to specifically recognize and bind to methylated histone tails, a key feature in the epigenetic control of gene expression. This remodeling activity is essential for various cellular processes, including transcriptional regulation, DNA repair, and chromosome organization. CHD proteins can act as both activators and repressors of transcription, depending on the context and specific interactions with other regulatory molecules. Their function and signaling pathways are tightly regulated, and dysregulation of CHD proteins is associated with developmental disorders, neurological disorders, and cancers.
Targeting CHD (chromodomain helicase DNA-binding) proteins with small molecules for disruption or inhibition provides a valuable tool for understanding their mechanistic roles in cellular processes. For instance, inhibiting the ATPase activity of CHD proteins can reveal their role in chromatin remodeling and its impact on transcriptional regulation. Additionally, using small molecule inhibitors to block the interaction between CHD proteins and methylated histones can help in determining how these proteins recognize and bind to specific chromatin marks.
VOIR ÉGALEMENT...
Items 11 to 14 of 14 total
Afficher:
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
Inhibiteur spécifique d'EZH2 affectant indirectement le CHD (chromodomaine hélicase de liaison à l'ADN) en ciblant le complexe répressif de Polycomb 2 (PRC2) et en modifiant la structure de la chromatine. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Modifie indirectement la CHD (chromodomaine hélicase de liaison à l'ADN) en influençant les récepteurs de l'acide rétinoïque et les voies de signalisation en aval, ce qui a un impact sur l'expression et l'activité de la CHD (chromodomaine hélicase de liaison à l'ADN). | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
Double inhibiteur de la lysine-déméthylase spécifique 1 (LSD1) et des histones-désacétylases, ayant un impact indirect sur la CHD (chromodomaine hélicase de liaison à l'ADN) en modulant les modifications des histones. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibiteur de la topoisomérase I qui module indirectement la CHD (chromodomaine hélicase se liant à l'ADN) en induisant des dommages à l'ADN et en influençant la structure de la chromatine, affectant la liaison et l'activité de la CHD (chromodomaine hélicase se liant à l'ADN). | ||||||